Market Cap 63.58M
Revenue (ttm) 0.00
Net Income (ttm) -7.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 82,457
Avg Vol 233,926
Day's Range N/A - N/A
Shares Out 9.63M
Stochastic %K 8%
Beta 1.03
Analysts Strong Sell
Price Target $16.33

Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic aller...

Industry: Biotechnology
Sector: Healthcare
Phone: 289 800 9600
Address:
100 Spy Court, Markham, Canada
AllmightyDollah
AllmightyDollah Jul. 20 at 8:47 PM
$EDSA $EDSA Fack butter chicken! Fack eating bug soup in the Spy Court lunchroom. Fuck all this Sharia Law on Spy Count. Fack Nashani. Fack Gary x2. Fack Micheal and Fack Canada!! Fack Pardeep Kumar Nijhawan the pos scammer!
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 8:31 PM
$EDSA don’t worry guys. The Velan offering years ago was for the vitiligo program. We should have results anyday. Oh um never mind. That was just free cash for employees that don’t do shit. No worries Par decided to stop lying and promised the vitiligo trial will definitely start latest mid year 2026. Um oh um. Nevermind. Maury says that’s a lie too. You need a new Hero Joe rather than this Pakistani scammer!
0 · Reply
KennyP007
KennyP007 Jul. 20 at 8:25 PM
$EDSA Dead Stock Walking
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 8:01 PM
$EDSA -12% on. O news less than 100k shares. Scamfest bs!
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 7:57 PM
$EDSA Par is NOT the man. He is a scammer who dropped stock price from $20 to $4 to do an offering. A terrible man.
0 · Reply
Treb3k
Treb3k Jul. 20 at 7:56 PM
$EDSA of course… they usually take the months of July and August off. thats why they needed some financing, they dont work this quarter.
1 · Reply
JoeDomiano
JoeDomiano Jul. 20 at 6:57 PM
$EDSA The Man
0 · Reply
JoeDomiano
JoeDomiano Jul. 20 at 6:56 PM
$EDSA I think we'll be in a 6-8 trading range for some time. Don't think there will be any big news soon. That's ok. We wait for the BARDA results. The Man has shown great ability to pull rabbits out of his hat to keep things rolling without major dilution. Patience.
1 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 5:51 PM
$EDSA 6month head n shoulders calls for $1.
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 2:14 PM
$EDSA Canada you rock!
0 · Reply
Latest News on EDSA
Edesa Biotech files to sell 729,241 common shares for holders

2026-07-02T21:05:18.000Z - 18 days ago

Edesa Biotech files to sell 729,241 common shares for holders


Edesa Biotech reinstated with a Buy at Brookline

2026-06-29T19:50:30.000Z - 21 days ago

Edesa Biotech reinstated with a Buy at Brookline


Edesa Biotech announces $3.5M private placement

2026-06-11T13:27:38.000Z - 5 weeks ago

Edesa Biotech announces $3.5M private placement


Edesa Biotech Inc trading resumes

2026-05-19T13:40:50.000Z - 2 months ago

Edesa Biotech Inc trading resumes


Edesa Biotech Inc trading halted, volatility trading pause

2026-05-19T13:35:48.000Z - 2 months ago

Edesa Biotech Inc trading halted, volatility trading pause


Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

May 14, 2026, 4:30 PM EDT - 2 months ago

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results


Edesa Biotech Inc trading halted, volatility trading pause

2026-04-28T14:26:55.000Z - 2 months ago

Edesa Biotech Inc trading halted, volatility trading pause


Edesa Biotech Inc trading resumes

2026-04-28T14:20:13.000Z - 2 months ago

Edesa Biotech Inc trading resumes


Edesa Biotech provides update on EB06 clinical study

2026-03-26T13:37:21.000Z - 4 months ago

Edesa Biotech provides update on EB06 clinical study


Edesa Biotech reports Q1 EPS (28c), consensus (45c)

2026-02-13T21:25:18.000Z - 5 months ago

Edesa Biotech reports Q1 EPS (28c), consensus (45c)


Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Feb 13, 2026, 4:20 PM EST - 5 months ago

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results


Edesa Biotech Reports Fiscal Year 2025 Results

Dec 12, 2025, 4:20 PM EST - 7 months ago

Edesa Biotech Reports Fiscal Year 2025 Results


Edesa Biotech Announces Upcoming Conference Schedule

Oct 31, 2025, 4:30 PM EDT - 9 months ago

Edesa Biotech Announces Upcoming Conference Schedule


Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Aug 8, 2025, 4:35 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results


Edesa Biotech files $150M mixed securities shelf

2025-07-25T20:50:18.000Z - 1 year ago

Edesa Biotech files $150M mixed securities shelf


Edesa Biotech assumed with a Buy at H.C. Wainwright

2025-06-27T14:35:08.000Z - 1 year ago

Edesa Biotech assumed with a Buy at H.C. Wainwright


Edesa Biotech initiated with a Buy at Lucid Capital

2025-05-23T10:55:53.000Z - 1 year ago

Edesa Biotech initiated with a Buy at Lucid Capital


Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

May 14, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results


Edesa Biotech Announces Chief Financial Officer Transition

Apr 4, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Announces Chief Financial Officer Transition


Edesa Biotech files to sell 7.81M common shares for holders

2025-03-04T21:36:26.000Z - 1 year ago

Edesa Biotech files to sell 7.81M common shares for holders


Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Feb 14, 2025, 4:15 PM EST - 1 year ago

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results


Edesa Biotech Reports Fiscal Year 2024 Results

Dec 13, 2024, 4:30 PM EST - 1 year ago

Edesa Biotech Reports Fiscal Year 2024 Results


Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Aug 9, 2024, 4:20 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results


Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

May 10, 2024, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results


Edesa Biotech to Participate in Upcoming Investor Conferences

Apr 2, 2024, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Investor Conferences


Edesa Biotech to Participate in Upcoming Dermatology Meetings

Mar 4, 2024, 4:30 PM EST - 2 years ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings


Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Feb 9, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results


Edesa Biotech Reports Fiscal Year 2023 Results

Dec 15, 2023, 4:10 PM EST - 2 years ago

Edesa Biotech Reports Fiscal Year 2023 Results


Edesa Biotech to Present at Dermatology Drug Development Summit

Oct 26, 2023, 4:05 PM EDT - 2 years ago

Edesa Biotech to Present at Dermatology Drug Development Summit


Edesa Biotech Announces One-for-Seven Reverse Share Split

Oct 10, 2023, 9:00 AM EDT - 3 years ago

Edesa Biotech Announces One-for-Seven Reverse Share Split


Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Aug 9, 2023, 4:15 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal Third Quarter 2023 Results


Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Jun 27, 2023, 8:15 AM EDT - 3 years ago

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role


Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

Jun 15, 2023, 8:00 AM EDT - 3 years ago

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name


Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

May 11, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results


Edesa Biotech to Participate in Swiss Biotech Day

Apr 20, 2023, 8:30 AM EDT - 3 years ago

Edesa Biotech to Participate in Swiss Biotech Day


Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Feb 10, 2023, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results


AllmightyDollah
AllmightyDollah Jul. 20 at 8:47 PM
$EDSA $EDSA Fack butter chicken! Fack eating bug soup in the Spy Court lunchroom. Fuck all this Sharia Law on Spy Count. Fack Nashani. Fack Gary x2. Fack Micheal and Fack Canada!! Fack Pardeep Kumar Nijhawan the pos scammer!
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 8:31 PM
$EDSA don’t worry guys. The Velan offering years ago was for the vitiligo program. We should have results anyday. Oh um never mind. That was just free cash for employees that don’t do shit. No worries Par decided to stop lying and promised the vitiligo trial will definitely start latest mid year 2026. Um oh um. Nevermind. Maury says that’s a lie too. You need a new Hero Joe rather than this Pakistani scammer!
0 · Reply
KennyP007
KennyP007 Jul. 20 at 8:25 PM
$EDSA Dead Stock Walking
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 8:01 PM
$EDSA -12% on. O news less than 100k shares. Scamfest bs!
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 7:57 PM
$EDSA Par is NOT the man. He is a scammer who dropped stock price from $20 to $4 to do an offering. A terrible man.
0 · Reply
Treb3k
Treb3k Jul. 20 at 7:56 PM
$EDSA of course… they usually take the months of July and August off. thats why they needed some financing, they dont work this quarter.
1 · Reply
JoeDomiano
JoeDomiano Jul. 20 at 6:57 PM
$EDSA The Man
0 · Reply
JoeDomiano
JoeDomiano Jul. 20 at 6:56 PM
$EDSA I think we'll be in a 6-8 trading range for some time. Don't think there will be any big news soon. That's ok. We wait for the BARDA results. The Man has shown great ability to pull rabbits out of his hat to keep things rolling without major dilution. Patience.
1 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 5:51 PM
$EDSA 6month head n shoulders calls for $1.
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 2:14 PM
$EDSA Canada you rock!
0 · Reply
AllmightyDollah
AllmightyDollah Jul. 20 at 2:04 PM
$EDSA good job Pardeep!
0 · Reply
Makingmillions192
Makingmillions192 Jul. 19 at 7:10 PM
$LEXX Trend reversal confirmation “Let’s jump on our white horses and go for a bullish ride. Today’s candlestick has a white body and its close is above the confirmation level. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. The trend is also bullish and perhaps it is the right time to participate in bullish fervor. The market is signaling a potential new profit opportunity. Capitalize on this bullish opportunity without hesitation.” Melt up until data drops in Aug 🌋 💰 🧨 $SLS $RANI $VRTX $EDSA
1 · Reply
Boywithathorn
Boywithathorn Jul. 19 at 5:20 PM
$EDSA a great trading podcast of any of you guys want to check out.
1 · Reply
Boywithathorn
Boywithathorn Jul. 19 at 12:42 AM
$EDSA I do like we’ve risen from the ashes. But man I can’t get it out of my head the way Par facked regular shareholders on that 3.5 Pipe. They literally took it from $20 to $4 in a month and did an offering the day it hit its lowest price. It’s insane you guys aren’t blown away by that. It’s crazy to me Par would risk his reputation and other regulations doing that. It was blatant in our face shenanigans. And here we are no news. No trials nothing but stock price decline again. Do these Canadians have a spine?
1 · Reply
MikiTrader
MikiTrader Jul. 18 at 4:50 PM
$EDSA They have held up quite well even during the recent biotech downturn. No, I believe they are holding up well. Hang in there. It's estimated that a company operating in such a textbook manner possesses considerable power not included in the public disclosure
1 · Reply
MasonRe1
MasonRe1 Jul. 18 at 12:20 AM
$EDSA lets go
0 · Reply
Boywithathorn
Boywithathorn Jul. 17 at 8:18 PM
$EDSA Did Edesa move their office on Spy Court? Address now says for lease.
1 · Reply
Boywithathorn
Boywithathorn Jul. 17 at 2:04 AM
$EDSA what makes it interesting as hell here as well is the 3.5 million pipe. Par reached the 75 million cap that bypassed the 1/3 dilution of highest average below 75 million cap a few months ago. He could have literally done a 100 million offering if he wanted as stated on s3. The dude instead did a 3.5. That in itself says the drug trials are over. It’s selling time.
0 · Reply
Boywithathorn
Boywithathorn Jul. 16 at 10:02 PM
$EDSA do yall really think Edesa will do another trial? I just don’t see it happening. Not with this crew and the eb01 screw up. And the 3.5 million Pipe was a joke. Par only did that to dilute just enough to get himself another few hundred thousand shares. It’s a given the drug rights or whole company will be sold. Probably not blockbuster amount but $22-$25 sounds fair and reasonable for most shareholders. It’s just how long they let this ride out before announcing? Who knows but eb06 not being announced it’s plain as day this is the deal.
1 · Reply
Boywithathorn
Boywithathorn Jul. 16 at 9:11 PM
$EDSA 92 cents pre split. Marvelous!
1 · Reply
Treb3k
Treb3k Jul. 16 at 8:43 PM
0 · Reply
Boywithathorn
Boywithathorn Jul. 16 at 8:41 PM
$EDSA mid year eb06 trial huh. Lmfao. It’s about to be August. Absolutely an abomination anyone gets paid at this company. Scammy scam scam scam.
0 · Reply